Related Experiment Video
Updated: Feb 15, 2026
08:27
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
8.1K
Inflammatory bowel disease: towards a personalized medicine
Mathurin Flamant1, Xavier Roblin2
1CHU Hotel Dieu, Institut des Maladies de l'Appareil Digestif, Place Ricordeau, 44093 Nantes and Clinique Jules Verne, Nantes, France.
Therapeutic Advances in Gastroenterology
|February 1, 2018
Summary
Personalized medicine and telemedicine are transforming inflammatory bowel disease (IBD) management. These approaches aim to tailor treatments and improve patient outcomes for IBD.
Area of Science:
- Gastroenterology and Immunology
- Pharmacology and Therapeutics
Background:
- The management of inflammatory bowel disease (IBD) has evolved significantly with biologics like anti-tumor necrosis factor (TNF) agents.
- Newer therapies targeting leukocyte trafficking (vedolizumab) and cytokines (ustekinumab), along with emerging treatments (JAK inhibitors, antisense oligonucleotides), offer alternative mechanisms of action.
Purpose of the Study:
- To review the current application of personalized medicine in IBD management.
- To discuss the role and limitations of telemedicine in optimizing IBD patient care.
Main Methods:
- Literature review of recent advancements in IBD therapeutics.
- Analysis of personalized medicine strategies for predicting treatment response.
- Evaluation of telemedicine's impact on IBD patient adherence and outcomes.
Main Results:
- Personalized medicine seeks to identify patients at high risk for progression and those who will preferentially respond to specific therapies.
- Predictive factors for drug response are crucial for tailoring IBD treatment.
- Telemedicine demonstrates potential to improve medical adherence, quality of life, and health outcomes in IBD patients.
Conclusions:
- Novel therapeutic targets and personalized medicine approaches are essential for managing aggressive or refractory IBD.
- Telemedicine offers a valuable tool for remote patient monitoring and enhancing IBD care.
- Integrating personalized medicine and telemedicine can optimize treatment strategies and patient well-being in IBD.
Keywords:
Crohn’s diseaseinflammatory bowel diseasepersonalized medicineremote patient caretelemedicineulcerative colitisMore Related Videos
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.2K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.2K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
01:21Inflammatory Bowel Disease V: Surgical Management
672
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
672
01:29Inflammatory Bowel Disease IV: Pharmacological Management
766
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
766
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
869
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
869
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K